Similar articles

• Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma.

  Mittelman A, Chen ZJ, Yang H, Wong GY, Ferrone S. Mittelman A, et al. Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):466-70. doi: 10.1073/pnas.89.2.466. Proc Natl Acad Sci U S A. 1992. PMID: 1731316 Free PMC article. Clinical Trial.
• Human high molecular weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody MK2-23. Characterization of the immunogenicity in syngeneic hosts.

  Chen ZJ, Yang H, Ferrone S. Chen ZJ, et al. J Immunol. 1991 Aug 1;147(3):1082-90. J Immunol. 1991. PMID: 1861071
• Modulation by adjuvants and carriers of the immunogenicity in xenogeneic hosts of mouse anti-idiotypic monoclonal antibody MK2-23, an internal image of human high molecular weight-melanoma associated antigen.

  Chen ZJ, Yang H, Liu CC, Hirai S, Ferrone S. Chen ZJ, et al. Cancer Res. 1993 Jan 1;53(1):112-9. Cancer Res. 1993. PMID: 8416734
• Antiantiidiotypic response and clinical course of the disease in patients with malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.

  Mittelman A, Wang X, Matsumoto K, Ferrone S. Mittelman A, et al. Hybridoma. 1995 Apr;14(2):175-81. doi: 10.1089/hyb.1995.14.175. Hybridoma. 1995. PMID: 7590776 Review.
• Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibodies MK2-23. Experimental studies and clinical trials in patients with malignant melanoma.

  Ferrone S, Chen ZJ, Liu CC, Hirai S, Kageshita T, Mittelman A. Ferrone S, et al. Pharmacol Ther. 1993 Feb-Mar;57(2-3):259-90. doi: 10.1016/0163-7258(93)90058-l. Pharmacol Ther. 1993. PMID: 8361995 Review.